Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Visceral Pain Market?

There has been a significant expansion in the market size of visceral pain in the previous years. The market, which was valued at $13.84 billion in 2024, is expected to surge to $14.82 billion in 2025, at a compound annual growth rate (CAGR) of 7.1%. Factors such as an aging populace, a rise in chronic diseases, advancements in medical studies, an expanded healthcare system, and heightened awareness and diagnosis rates have contributed to the growth during the historic period.

Strong expansion is anticipated in the visceral pain market over the coming years, with predictions showing a growth to $18.58 billion in 2029, and a compound annual growth rate (CAGR) of 5.8%. Factors contributing to growth during the forecast period include advancements in pain management technology, an increasing preference for non-invasive treatments, emerging and untapped markets, personalized treatment strategies, and the integration of digital health solutions. The forecast period will also see trends such as a shift towards multi-faceted pain management methods, a heightened focus on alternative therapies, the emergence of targeted treatments for specific pain types, the expanding role of telemedicine in managing pain, and the incorporation of artificial intelligence in pain assessment.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

What Drivers Are Accelerating Expansion Of The Visceral Pain Market?

The upward trend in analgesics demand is anticipated to propel the visceral pain market’s expansion. Analgesics, pain-relieving drugs that function by reducing or inhibiting the perception of pain signals in the brain, play a crucial role in managing visceral pain by interacting with the nervous system to alter pain signals from internal organs. For instance, in a report by the New England Journal of Medicine in April 2024, over 53,600 clinicians in the UK had been prescribing buprenorphine by December 2023 – an increment of 11,500 prescribers from the previous year, December 2022. Hence, the escalating demand for analgesics is fueling the growth of the visceral pain market.

What Are The Key Segment Trends Observed In The Visceral Pain Market?

The visceral painmarket covered in this report is segmented –

1) By Drug Class: Calcium Channel Blockers; Nonsteroidal Anti-Inflammatory (NSAID); Other Drug Classes

2) By Indications: Interstitial Cystitis; Crohn’s; Irritable Bowel; Chronic Prostatitis; Other Indications

3) By End Users: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Calcium Channel Blockers: Dihydropyridines; Non-Dihydropyridines

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors; Non-Selective NSAIDs

3) By Other Drug Classes: Opioids; Tricyclic Antidepressants (TCAs); Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

Which Disruptive Trends Are Driving Change Across The Visceral Pain Market?

Leading firms in the visceral pain market are in the process of creating cutting-edge products like NHE3 Inhibitor to offer trustworthy services to their clients. NHE3 inhibitors belong to a category of drugs that function by obstructing the Sodium-Proton-Exchanger subtype 3 (NHE3) found in the gut. To exemplify, in April 2022, the biopharmaceutical company based in the United States, Ardelyx, introduced an NHE3 Inhibitor medication, known as IBSRELA. IBSRELA is a ground-breaking treatment for adults suffering from irritable bowel syndrome with constipation (IBS-C) and it functions by impeding the Sodium-Hydrogen Exchanger 3 (NHE3) in the small intestine and colon. It has demonstrated the capacity to alleviate abdominal pain as it reduces visceral hypersensitivity and intestinal permeability, as evidenced by animal studies.

Who Are The Major Stakeholders Operating In The Visceral Pain Market?

Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

What Regional Factors Are Accelerating Growth In The Visceral Pain Market?

North America was the largest region in the visceral pain market in 2024. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13950&type=smp

Browse Through More Reports Similar to the Global Visceral Pain Market 2025, By The Business Research Company

Neuropathic Pain Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Joint Pain Injections Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Veterinary Pain Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model